Rosenstock J, Banarer S, Fonseca VA et al (2010) The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy
The initial approved regimen was 5 g subcutaneous injection twice daily, given within 60 minutes before morning and evening meals, titratable to 10 g BID
Manufacturer Guidelines Almost all reputable manufacturers provide storage recommendations on the product label
In 2011 a paper titled IGF-1 levels are significantly correlated with patient-reported measures of sexual function found that growth hormone (GH) supplementation may help to preserve erectile function
GHK-Cu increases follicle size, stimulating blood flow, and providing anti-inflammatory benefits
Browse results from across our surgical and non-surgical procedures